Hostname: page-component-5d84bcc8dc-kzmd4 Total loading time: 0 Render date: 2026-09-09T10:26:05.075Z Has data issue: false hasContentIssue false
  • English
  • Français

A fraction derived from brewer's yeast inhibits cholesterol synthesis by rat liver preparations in vitro

Published online by Cambridge University Press:  09 March 2007

E. S. Holdsworth ,
D. V. Kaufman  and
E. Neville
E. S. Holdsworth
Affiliation:
Biochemistry Department, University of Tasmania, Hobart, Tasmania, Australia
D. V. Kaufman
Affiliation:
Biochemistry Department, University of Tasmania, Hobart, Tasmania, Australia
E. Neville
Affiliation:
Biochemistry Department, University of Tasmania, Hobart, Tasmania, Australia
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

Brewer's yeast was grown on a defined medium containing tracer 51Cr with or without added chromium. The two batches of yeast contained 10 μg/g (high-Cr) or 80 ng/g (low-Cr). Extracts were prepared and fractionated. A third batch of yeast (third batch) was grown with added Cr, and fractionated. Rats were reared on either rat cubes (normal diet) or on a low-Cr diet (low-Cr), or on rat cubes with added cholestyramine (cholestyramine diet). Preparations of rat liver, both cell-free and intact hepatocytes, incorporated acetate-carbon into fatty acids and cholesterol. These processes were inhibited by a yeast fraction containing small, neutral, water-soluble compounds. The degree of inhibition was the same whether the liver came from normal rats or rats fed on the low-Cr diet. Similarly the inhibitory effect was found with identical amounts of extracts from low- or high-Cr yeasts. Therefore, Cr compounds do not appear to account for the inhibitory effects of brewer's yeast. Use of other substrates indicated that the site of inhibition of sterol synthesis was apparently between acetyl-CoA and mevalonate. One inhibitory substance was isolated from yeast and was found to be nicotinamide riboside. This may have been produced from NAD(P) during the preparation of yeast extracts, and it may be produced from dietary yeast supplements during digestion in vivo. Nicotinamide riboside may be partly responsible for the reported effects of yeast supplements on plasma lipids in humans.

Keywords

Brewer's yeastChromiumCholesterol biosynthesisRat

Information

Type
Metabolic Effects of Dietary Constituents
Information
British Journal of Nutrition , Volume 65 , Issue 2 , March 1991 , pp. 285 - 299
Copyright
Copyright © The Nutrition Society 1991

References

REFERENCES

Abraham, A. S., Sonnenblick, M. & Eini, M. (1982). The effect of chromium on cholesterol-induced atherosclerosis in rabbits. Atherosclerosis 41, 371–379.Google Scholar
Allen, J. K., Hensley, W. J., Nicholls, A. V. & Whitfield, J. B. (1979). An enzymic and centrifugal method for estimating high-density lipoprotein cholesterol. Clinical Chemistry 25, 325–327.CrossRefGoogle ScholarPubMed
Bernofsky, C. & Gallacher, W. J. (1975). Lipid chromatography of pyridine nucleotides and associated compounds and isolation of several analogues of NADP. Analytical Biochemistry 67, 611–624.CrossRefGoogle Scholar
Bourn, D. M., Gibson, R. S., Martinez, O. B. & MacDonald, A. C. (1986). The effect of chromium supplementation on serum lipid levels in a selected sample of Canadian post-menopausal women. Biological Trace Element Research 9, 197–205.CrossRefGoogle Scholar
Brown, M. S. & Goldstein, J. L. (1986). A receptor-mediated pathway for cholesterol homeostasis. Science 232, 34–47.CrossRefGoogle ScholarPubMed
Chang, T. Y., Schiavoni, E. S. & McCrae, K. R. (1979). Inhibition of cholesterol biosynthesis in chinese hamster ovary by 4,4,10-trimethyl-trans-decal-3-ol. Journal of Biological Chemistry 254, 11258–11263.CrossRefGoogle Scholar
Cighetti, G., Del Puppo, M., Paroni, R., Galli, G. & Galli Kienle, M. (1986). Effects of pantethine on cholesterol synthesis from mevalonate in isolated rat hepatocytes. Atherosclerosis 60, 67–77.Google Scholar
Conri, C. I., Simonoff, M., Besse, P., Llabador, Y., Fleury, B. & Simonoff, G. N. (1986). Baise du chrome plasmatique au tours des coronaropathies. La Presse Médicale 15, 1931.Google Scholar
Davies, D., Holdsworth, E. S. & Sherriff, J. L. (1985). The isolation of glucose tolerance factors from brewer's yeast and their relationship to chromium. Biochemical Medicine 33, 297–311.CrossRefGoogle ScholarPubMed
Donaldson, D. L., Lee, D. M., Smith, C. C. & Rennert, O. M. (1985). Glucose tolerance and plasma lipid distributions in rats fed a high-sucrose, high-cholesterol, low-chromium diet. Metabolism 34, 1086–1093.CrossRefGoogle ScholarPubMed
Elwood, J. C., Nash, D. T. & Streeton, D. H. P. (1982). Effect of high-chromium brewer's yeast on human serum lipids. Journal of the American College of Nutrition 1, 263–274.CrossRefGoogle ScholarPubMed
Goodwin, C. D. & Margolis, S. (1978). Cyclic AMP-sensitive activation of hepatic sterol synthesis and 3-hydroxy-3-methylglutaryl coenzyme A reductase. Journal of Lipid Research 19, 747–756.CrossRefGoogle ScholarPubMed
Grant, A. P. & McMullen, J. K. (1982). The effect of brewer's yeast containing glucose tolerance factor on the response to treatment in type 2 diabetics. A short controlled study. Ulster Medical Journal 51, 110–114.Google Scholar
Holdsworth, E. S. & Neville, E. (1988). Extracts of brewer's yeast contain GABA which enhances activation of glycogen synthetase by insulin in isolated rat hepatocytes. Biochemistry International 17, 1107–1116.Google ScholarPubMed
Holdsworth, E. S. & Neville, E. (1990). Effects of extracts of high- and low-chromium brewer's yeast on metabolism of glucose by hepatocytes from rats fed on high- or low-chromium diet. British Journal of Nutrition 63, 623–630.Google Scholar
Holland, R., Witters, L. A. & Hardie, G. (1984). Glucagon inhibits fatty acid synthesis in isolated hepatocytes via phosphorylation of acetyl CoA carboxylase by cyclic-AMP-dependent protein kinase. European Journal of Biochemistry 140, 325–333.CrossRefGoogle ScholarPubMed
Hunt, A. E., Alan, K. G. D. & Smith, B. A. (1985). Effect of chromium supplementation on hair chromium concentration and diabetic status. Nutrition Research 5, 131–140.CrossRefGoogle Scholar
Ingebritson, T. S. & Gibson, D. M. (1981). Assay of enzymes that modulate S-3-hydroxy-3-methylglutaryl-CoA reductase by reversible phosphorylation. Methods in Enzymology 71, 486–497.Google Scholar
Kuroda, M. & Endo, A. (1977). Inhibition of in vitro cholesterol synthesis by fatty acids. Biochimica et Biophysica Acta 486, 70–81.Google Scholar
Lakshman, M. R. & Veech, R. L. (1977). Measurement of rate of rat liver sterol synthesis in vivo using tritiated water. Journal of Biological Chemistry 252, 4667–4673.CrossRefGoogle Scholar
Layne, E. (1957). Spectrophotometric and turbidimetric methods for measuring proteins. Methods in Enzymology 3, 447–454.CrossRefGoogle Scholar
Li, Y.-C. & Stoecker, B. J. (1986). Chromium and yoghurt effects on hepatic lipid and plasma glucose and insulin of obese mice. Biological Trace Element Research 9, 233–242.Google Scholar
Loesche, W., Wenz, I., Till, U., Petermann, H. & Horn, A. (1980). Purification of commercial NADH. Methods in Enzymology 66, 11–22.CrossRefGoogle ScholarPubMed
Lohr, G. H. & Waller, H. D. (1974). Methods for determination of enzymic activity: glucose-6-phosphate dehydrogenase. In Methods of Enzymatic Analysis, vol. 2, pp. 636–643. [Bergmeyer, H. U., editor]. New York: Academic Press.CrossRefGoogle Scholar
Miller, N. E., Forde, O. H., Thelle, D. S. & Mjos, O. D. (1977). The Tromso heart study. High density lipoprotein and coronary heart disease: a prospective case-control study. Lancet i, 965–968.CrossRefGoogle Scholar
Ness, G. C., Sample, C. E., Smith, M., Pendleton, L. C. & Eicher, D. C. (1986). Characteristics of rat liver microsomal 3-hydroxy-3-methylglutaryl coenzyme A reductase. Biochemical Journal 233, 167–172.CrossRefGoogle ScholarPubMed
Newman, H. A. I., Leighton, R. F., Lanese, R. R. & Freedland, N. A. (1978). Serum chromium and angiographically determined coronary artery disease. Clinical Chemistry 24, 541–544.CrossRefGoogle ScholarPubMed
Offenbacher, E. G. & Pi-Sunyer, F. X. (1980). Beneficial effect of chromium-rich yeast on glucose tolerance and blood lipids in elderly subjects. Diabetes 29, 919–925.CrossRefGoogle ScholarPubMed
Offenbacher, E. G., Rinko, C. J. & Pi-Sunyer, F. X. (1985). The effects of inorganic chromium and brewer's yeast on glucose tolerance, plasma lipids and plasma chromium in elderly subjects. American Journal of Clinical Nutrition 42, 454–461.CrossRefGoogle ScholarPubMed
Potter, J. F., Levin, P., Anderson, R. A., Freiberg, J. M., Andres, R. & Elahi, D. (1985). Glucose metabolism in glucose intolerant older people during chromium supplementation. Metabolism 34, 199–204.CrossRefGoogle ScholarPubMed
Preston, A. M., Dowdy, R. P., Preston, M. A. & Freeman, J. N. (1976). Effect of dietary chromium on glucose tolerance and serum cholesterol in guinea pigs. Journal of Nutrition 106, 1391–1397.CrossRefGoogle ScholarPubMed
Rabinowitz, M. B., Gonick, H. C., Levin, S. R. & Davidson, M. B. (1983). Effects of chromium and yeast supplements on carbohydrate and lipid metabolism in diabetic men. Diabetes Care 6, 319–327.CrossRefGoogle ScholarPubMed
Ranganathan, S., Jackson, R. L. & Harmony, J. A. K. (1982). Effect of pantethine on the biosynthesis of cholesterol in human skin fibroblasts. Atherosclerosis 44, 261–273.CrossRefGoogle ScholarPubMed
Riales, R. & Albrink, M. J. (1981). Effect of chromium chloride supplementation on glucose tolerance and serum lipids including high-density lipoprotein of adult men. American Journal of Clinical Nutrition 34, 2670–2678.CrossRefGoogle ScholarPubMed
Roitelman, J. & Schecter, I. (1984). Regulation of rat liver 3-hydroxy-3-methylglutaryl coenzyme A reductase. Journal of Biological Chemistry 259, 870–877.CrossRefGoogle ScholarPubMed
Roitelman, J. & Schecter, I. (1986). Altered kinetic properties of rat liver 3-hydroxy-3-methylglutaryl coenzyme A reductase following dietary manipulations. Journal of Biological Chemistry 261, 5061–5066.CrossRefGoogle Scholar
Schroeder, H. A. (1969). Serum cholesterol and glucose levels in rats fed refined and less refined sugars and chromium. Journal of Nutrition 97, 237–242.CrossRefGoogle ScholarPubMed
Schwarz, K. (1951). Production of dietary necrotic liver degeneration using American Torula yeast. Proceedings of the Society for Experimental Biology and Medicine 77, 818–823.CrossRefGoogle ScholarPubMed
Schwarz, K. & Mertz, W. (1959). Chromium III and the glucose tolerance factor. Archives of Biochemistry and Biophysics 85, 292–295.CrossRefGoogle ScholarPubMed
Simonoff, M., Llabador, Y., Hamon, C., Peers, A. M. & Simonoff, G. N. (1984). Low plasma chromium in patients with coronary artery and heart disease. Biological Trace Element Research 6, 431–439.CrossRefGoogle Scholar
Smith, I. (1969). Chromatographic and Electrophoretic Techniques. vol. 1, 3rd ed., p. 104. Bath: Pitman.Google Scholar
Stoecker, B. J. & Oladut, W. K. (1985). Effects of chromium and ascorbate deficiencies on glucose tolerance and serum cholesterol of guinea pigs. Nutrition Reports International 32, 399–405.Google Scholar
Uusitupa, M. I. J., Kumpulainen, J. T., Voutilainen, E., Hersio, K., Sarlund, H., Pyorala, K. P., Kiovistoinen, P. E. & Lehto, J. T. (1983). Effect of inorganic chromium supplementation on glucose tolerance, insulin response, and serum lipids in non-insulin-dependent diabetes. American Journal of Clinical Nutrition 38, 404–410.Google Scholar
Vinson, J. A. & Bose, P. (1984). The effect of a high-chromium yeast on the blood glucose control and blood lipids of normal and diabetic human subjects. Nutrition Reports International 30, 911–918.Google Scholar
Wallach, S. (1985). Clinical and biochemical aspects of chromium deficiency. Journal of the American College of Nutrition 4, 107–120.CrossRefGoogle ScholarPubMed